Table of Content
1 Report Prologue
2 Executive Summary
3 Market Introduction
3.1 Definition
3.2 Scope of the Study
3.3 Research Objective
3.4 Assumptions & Limitations
3.4.1 Assumptions
3.4.2 Limitations
3.5 Market Structure
4 Research Methodology
4.1 Research Process
4.2 Primary Research
4.3 Secondary Research
4.4 Market Size Estimation
4.5 Forecast Model
5 Market Dynamics
5.1 Introduction
5.2 Drivers
5.2.1 Rising prevalence of autoimmune diseases
5.2.2 Increasing research and development related to plasma-derived medicines
5.2.3 Increasing awareness about Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
5.3 Restraints
5.3.1 Side-effects associated with the Intravenous Immunoglobulin (IVIG) treatment
5.3.2 High cost of the IVIG treatment
5.4 Opportunity
5.4.1 Advancements in the treatment
5.5 Clinical Trials Data
6 Market Factor Analysis
6.1 Porter’s Five Forces Model
6.1.1 Bargaining Power of Suppliers
6.1.2 Bargaining Power of Buyers
6.1.3 Threat of New Entrants
6.1.4 Threat of Substitutes
6.1.5 Intense Rivalry
6.2 Supply Chain Analysis
6.2.1 R&D and Designing
6.2.2 Manufacturing
6.2.3 Distribution & Sales
6.2.4 Post-Sales Monitoring
7 Global Chronic Inflammatory Demyelinating Polyneuropathy Market, By Treatment & Diagnosis
7.1 Introduction
7.2 Treatment
7.3 Diagnosis
8 Global Chronic Inflammatory Demyelinating Polyneuropathy Market, By Route of Administration
8.1 Introduction
8.2 Intravenous
8.3 Oral
9 Global Chronic Inflammatory Demyelinating Polyneuropathy Market, By End User
9.1 Introduction
9.2 Hospitals
9.3 Specialty Neurological Clinics
9.4 Research & Academic Laboratories
10 Global Chronic Inflammatory Demyelinating Polyneuropathy Market, By Region
10.1 Introduction
10.2 Americas
10.2.1 North America
10.2.1.1 U.S.
10.2.1.2 Canada
10.2.2 South America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 Germany
10.3.1.2 France
10.3.1.3 U.K
10.3.1.4 Italy
10.3.1.5 Spain
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 Republic of Korea
10.4.6 Rest of Asia Pacific
10.5 Middle East and Africa
10.5.1 Middle East
10.5.2 Africa
11 Competitive Landscape
11.1 Company Market Share Analysis
11.2 Introduction
12 Company Profiles
12.1 Grifols
12.1.1 Company Overview
12.1.2 Financial Overview
12.1.3 Products/Services Offered
12.1.4 SWOT Analysis
12.1.5 Key Developments
12.1.6 Key strategy
12.2 Shire
12.2.1 Company Overview
12.2.2 Financial Overview
12.2.3 Products/Services Offered
12.2.4 SWOT Analysis
12.2.5 Key Developments
12.2.6 Key strategy
12.3 Baxter
12.3.1 Company Overview
12.3.2 Company Overview
12.3.3 Products/Services Offered
12.3.4 SWOT Analysis
12.3.5 Key Developments
12.3.6 Key strategy
12.4 Pfizer, Inc.
12.4.1 Company Overview
12.4.2 Financial Overview
12.4.3 Products/Services Offered
12.4.4 SWOT Analysis
12.4.5 Key Developments
12.4.6 Key Strategy
12.5 CSL Behring
12.5.1 Company Overview
12.5.2 Financial Overview
12.5.3 Products/Services Offered
12.5.4 SWOT Analysis
12.5.5 Key Developments
12.5.6 Key Strategy
12.6 Kedrion S.p.A
12.6.1 Company Overview
12.6.2 Financial Overview
12.6.3 Products/Services Offered
12.6.4 SWOT Analysis
12.6.5 Key Development
12.6.6 Key Strategy
12.7 Octapharma
12.7.1 Company Overview
12.7.2 Financial Overview
12.7.3 Products/Services Offered
12.7.4 SWOT Analysis
12.7.5 Key Development
12.7.6 Key Strategy
12.8 Momenta Pharmaceuticals
12.8.1 Company Overview
12.8.2 Financial Overview
12.8.3 Products/Services Offered
12.8.4 SWOT Analysis
12.8.5 Key Development
12.8.6 Key Strategy
12.9 Teijin Pharma Limited
12.9.1 Company Overview
12.9.2 Financial Overview
12.9.3 Products/Services Offered
12.9.4 SWOT Analysis
12.9.5 Key Developments
12.9.6 Key strategy
12.1 Mitsubishi Tanabe Pharma Corporation
12.10.1 Company Overview
12.10.2 Financial Overview
12.10.3 Products/Services Offered
12.10.4 SWOT Analysis
12.10.5 Key Developments
12.11 Bio Products Laboratory Ltd.
12.11.1 Company Overview
12.11.2 Financial Overview
12.11.3 Products/Services Offered
12.11.4 SWOT Analysis
12.11.5 Key Developments
12.11.6 Key strategy
13 Appendix
13.1 Discussion Blue Print
List of Figures
FIGURE 1 RESEARCH PROCESS
FIGURE 2 TOP-DOWN & BOTTOM-UP APPROACH
FIGURE 3 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY
(CIDP) MARKET
FIGURE 4 PORTER’S FIVE FORCES ANALYSIS: GLOBAL CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET
FIGURE 5 SUPPLY CHAIN: GLOBAL CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET
FIGURE 6 GLOBAL CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET SHARE, BY TREATMENT & DIAGNOSIS 2017 (%)
FIGURE 7 GLOBAL CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY TREATMENT & DIAGNOSIS 2017 & 2023 (USD MILLION)
FIGURE 8 GLOBAL CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET SHARE, BY ROUTE OF
ADMINISTRATION, 2017 (%)
FIGURE 9 GLOBAL CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY ROUTE OF ADMINISTRATION 2017 & 2023 (USD MILLION)
FIGURE 10 GLOBAL CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET SHARE, BY END USER, 2017 (%)
FIGURE 11 GLOBAL CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY END USER, 2017 & 2023 (USD MILLION)
FIGURE 12 GLOBAL CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY REGION, 2017 & 2023 (USD MILLION)
FIGURE 13 GLOBAL CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET SHARE, BY REGION, 2017 (%)
FIGURE 14 AMERICAS CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET SHARE, BY REGION, 2017 (%)
FIGURE 15 EUROPE CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET SHARE, BY REGION, 2017 (%)
FIGURE 16 WESTERN EUROPE CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET SHARE, BY COUNTRY, 2017 (%)
FIGURE 17 ASIA PACIFIC CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET SHARE, BY COUNTRY, 2017 (%)
FIGURE 18 MIDDLE EAST AND AFRICA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET SHARE BY COUNTRY, 2017 (%)
FIGURE 19 GLOBAL CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP) MARKET SHARE ANALYSIS 2017 (%)
List of Tables
TABLE 1 MARKET SYNOPSIS
TABLE 2 PRIMARY INTERVIEWS
TABLE 3 GLOBAL CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET BY TREATMENT & DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 4 GLOBAL CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR TREATMENT BY TYPE 2015-2023 (USD MILLION)
TABLE 5 GLOBAL CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR DIAGNOSIS BY TYPE 2015-2023 (USD MILLION)
TABLE 6 GLOBAL CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR ELECTRODIAGNOSTIC TESTING
BY TYPE, 2015-2023 (USD MILLION)
TABLE 7 GLOBAL CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR TREATMENT BY REGION 2015-2023 (USD MILLION)
TABLE 8 GLOBAL CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR DIAGNOSIS BY REGION 2015-2023 (USD MILLION)
TABLE 9 GLOBAL CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET BY ROUTE OF ADMINISTRATION 2015-2023 (USD MILLION)
TABLE 10 GLOBAL CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR INTRAVENOUS BY REGION 2015-2023 (USD MILLION)
TABLE 11 GLOBAL CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR ORAL BY REGION 2015-2023 (USD MILLION)
TABLE 12 GLOBAL CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET BY END USER, 2015-2023 (USD MILLION)
TABLE 13 GLOBAL CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR HOSPITALS, BY REGION 2015-2023 (USD MILLION)
TABLE 14 GLOBAL CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR SPECIALTY NEUROLOGICAL CLINICS BY REGION, 2015-2023 (USD MILLION)
TABLE 15 GLOBAL CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR RESEARCH & ACADEMIC
LABORATORIES, BY REGION, 2015-2023 (USD MILLION)
TABLE 16 GLOBAL CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY REGION, 2015-2023 (USD MILLION)
TABLE 17 AMERICAS CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY REGION, 2015-2023 (USD MILLION)
TABLE 18 AMERICAS CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY TREATMENT & DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 19 AMERICAS CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR TREATMENT BY TYPE 2015-2023 (USD MILLION)
TABLE 20 AMERICAS CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR DIAGNOSIS BY TYPE 2015-2023 (USD MILLION)
TABLE 21 AMERICAS CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR ELECTRODIAGNOSTIC TESTING
BY TYPE, 2015-2023 (USD MILLION)
TABLE 22 AMERICAS CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY ROUTE OF ADMINISTRATION 2015-2023 (USD MILLION)
TABLE 23 AMERICAS CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY END USERS 2015-2023 (USD MILLION)
TABLE 24 NORTH AMERICA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY COUNTRY 2015-2023 (USD MILLION)
TABLE 25 NORTH AMERICA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET BY TREATMENT & DIAGNOSIS, 2015-2023 (USD MILLION)
TABLE 26 NORTH AMERICA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR TREATMENT
BY TYPE, 2015-2023 (USD MILLION)
TABLE 27 NORTH AMERICA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR DIAGNOSIS
BY TYPE, 2015-2023 (USD MILLION)
TABLE 28 NORTH AMERICA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR ELECTRODIAGNOSTIC
TESTING BY TYPE, 2015-2023 (USD MILLION)
TABLE 29 NORTH AMERICA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY ROUTE OF
ADMINISTRATION, 2015-2023 (USD MILLION)
TABLE 30 NORTH AMERICA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY END USERS 2015-2023 (USD MILLION)
TABLE 31 U. S. CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY TREATMENT & DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 32 U. S. CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR TREATMENT BY TYPE 2015-2023 (USD MILLION)
TABLE 33 U. S. CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR DIAGNOSIS BY TYPE 2015-2023 (USD MILLION)
TABLE 34 U. S. CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR ELECTRODIAGNOSTIC TESTING
BY TYPE, 2015-2023 (USD MILLION)
TABLE 35 U. S. CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY ROUTE OF ADMINISTRATION 2015-2023 (USD MILLION)
TABLE 36 U. S. CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY END USERS, 2015-2023 (USD MILLION)
TABLE 37 CANADA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY TREATMENT & DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 38 CANADA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR TREATMENT BY TYPE 2015-2023 (USD MILLION)
TABLE 39 CANADA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR DIAGNOSIS BY TYPE 2015-2023 (USD MILLION)
TABLE 40 CANADA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR ELECTRODIAGNOSTIC TESTING
BY TYPE, 2015-2023 (USD MILLION)
TABLE 41 CANADA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY ROUTE OF ADMINISTRATION 2015-2023 (USD MILLION)
TABLE 42 CANADA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY END USERS, 2015-2023 (USD MILLION)
TABLE 43 SOUTH AMERICA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY TREATMENT &
DIAGNOSIS, 2015-2023 (USD MILLION)
TABLE 44 SOUTH AMERICA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR TREATMENT BY TYPE 2015-2023 (USD MILLION)
TABLE 45 SOUTH AMERICA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR DIAGNOSIS BY TYPE 2015-2023 (USD MILLION)
TABLE 46 SOUTH AMERICA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR ELECTRODIAGNOSTIC
TESTING BY TYPE, 2015-2023 (USD MILLION)
TABLE 47 SOUTH AMERICA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY ROUTE OF
ADMINISTRATION, 2015-2023 (USD MILLION)
TABLE 48 SOUTH AMERICA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY END USERS 2015-2023 (USD MILLION)
TABLE 49 EUROPE CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY REGION, 2015-2023 (USD MILLION)
TABLE 50 EUROPE CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY TREATMENT & DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 51 EUROPE CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR TREATMENT BY TYPE 2015-2023 (USD MILLION)
TABLE 52 EUROPE CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR DIAGNOSIS BY TYPE 2015-2023 (USD MILLION)
TABLE 53 EUROPE CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR ELECTRODIAGNOSTIC TESTING
BY TYPE, 2015-2023 (USD MILLION)
TABLE 54 EUROPE CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY ROUTE OF ADMINISTRATION 2015-2023 (USD MILLION)
TABLE 55 EUROPE CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY END USERS, 2015-2023 (USD MILLION)
TABLE 56 WESTERN EUROPE CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY COUNTRY 2015-2023 (USD MILLION)
TABLE 57 WESTERN EUROPE CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY TREATMENT &
DIAGNOSIS, 2015-2023 (USD MILLION)
TABLE 58 WESTERN EUROPE CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR TREATMENT
BY TYPE, 2015-2023 (USD MILLION)
TABLE 59 WESTERN EUROPE CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR DIAGNOSIS
BY TYPE, 2015-2023 (USD MILLION)
TABLE 60 WESTERN EUROPE CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR ELECTRODIAGNOSTIC
TESTING BY TYPE, 2015-2023 (USD MILLION)
TABLE 61 WESTERN EUROPE CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY ROUTE OF
ADMINISTRATION, 2015-2023 (USD MILLION)
TABLE 62 WESTERN EUROPE CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY END USERS 2015-2023 (USD MILLION)
TABLE 63 GERMANY CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY TREATMENT & DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 64 GERMANY CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR TREATMENT BY TYPE 2015-2023 (USD MILLION)
TABLE 65 GERMANY CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR DIAGNOSIS BY TYPE 2015-2023 (USD MILLION)
TABLE 66 GERMANY CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR ELECTRODIAGNOSTIC TESTING
BY TYPE, 2015-2023 (USD MILLION)
TABLE 67 GERMANY CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY ROUTE OF ADMINISTRATION 2015-2023 (USD MILLION)
TABLE 68 GERMANY CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY END USERS 2015-2023 (USD MILLION)
TABLE 69 FRANCE CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY TREATMENT & DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 70 FRANCE CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR TREATMENT BY TYPE \2015-2023 (USD MILLION)
TABLE 71 FRANCE CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR DIAGNOSIS BY TYPE 2015-2023 (USD MILLION)
TABLE 72 FRANCE CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR ELECTRODIAGNOSTIC TESTING
BY TYPE, 2015-2023 (USD MILLION)
TABLE 73 FRANCE CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY ROUTE OF ADMINISTRATION 2015-2023 (USD MILLION)
TABLE 74 FRANCE CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY END USERS, 2015-2023 (USD MILLION)
TABLE 75 U.K CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY TREATMENT & DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 76 U.K CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR TREATMENT BY TYPE 2015-2023 (USD MILLION)
TABLE 77 U.K CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR DIAGNOSIS BY TYPE 2015-2023 (USD MILLION)
TABLE 78 U.K CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR ELECTRODIAGNOSTIC TESTING
BY TYPE, 2015-2023 (USD MILLION)
TABLE 79 U.K CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY ROUTE OF ADMINISTRATION 2015-2023 (USD MILLION)
TABLE 80 U.K CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY END USERS, 2015-2023 (USD MILLION)
TABLE 81 ITALY CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY TREATMENT & DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 82 ITALY CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR TREATMENT BY TYPE 2015-2023 (USD MILLION)
TABLE 83 ITALY CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR DIAGNOSIS BY TYPE 2015-2023 (USD MILLION)
TABLE 84 ITALY CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR ELECTRODIAGNOSTIC TESTING
BY TYPE, 2015-2023 (USD MILLION)
TABLE 85 ITALY CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY ROUTE OF ADMINISTRATION 2015-2023 (USD MILLION)
TABLE 86 ITALY CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY END USERS, 2015-2023 (USD MILLION)
TABLE 87 SPAIN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY TREATMENT & DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 88 SPAIN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR TREATMENT BY TYPE 2015-2023 (USD MILLION)
TABLE 89 SPAIN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR DIAGNOSIS BY TYPE 2015-2023 (USD MILLION)
TABLE 90 SPAIN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR ELECTRODIAGNOSTIC TESTING
BY TYPE, 2015-2023 (USD MILLION)
TABLE 91 SPAIN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY ROUTE OF ADMINISTRATION 2015-2023 (USD MILLION)
TABLE 92 SPAIN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY END USERS, 2015-2023 (USD MILLION)
TABLE 93 REST OF WESTERN EUROPE CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET BY TREATMENT & DIAGNOSIS, 2015-2023 (USD MILLION)
TABLE 94 REST OF WESTERN EUROPE CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR
TREATMENT BY TYPE, 2015-2023 (USD MILLION)
TABLE 95 REST OF WESTERN EUROPE CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR
DIAGNOSIS BY TYPE, 2015-2023 (USD MILLION)
TABLE 96 REST OF WESTERN EUROPE CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR
ELECTRODIAGNOSTIC TESTING BY TYPE, 2015-2023 (USD MILLION)
TABLE 97 REST OF WESTERN EUROPE CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET BY ROUTE OF ADMINISTRATION, 2015-2023 (USD MILLION)
TABLE 98 REST OF WESTERN EUROPE CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY END USERS 2015-2023 (USD MILLION)
TABLE 99 EASTERN EUROPE CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY TREATMENT &
DIAGNOSIS, 2015-2023 (USD MILLION)
TABLE 100 EASTERN EUROPE CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR TREATMENT
BY TYPE, 2015-2023 (USD MILLION)
TABLE 101 EASTERN EUROPE CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR DIAGNOSIS
BY TYPE, 2015-2023 (USD MILLION)
TABLE 102 EASTERN EUROPE CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR ELECTRODIAGNOSTIC
TESTING BY TYPE, 2015-2023 (USD MILLION)
TABLE 103 EASTERN EUROPE CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY ROUTE OF
ADMINISTRATION, 2015-2023 (USD MILLION)
TABLE 104 EASTERN EUROPE CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY END USERS 2015-2023 (USD MILLION)
TABLE 105 ASIA PACIFIC CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY COUNTRY 2015-2023 (USD MILLION)
TABLE 106 ASIA PACIFIC CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY TREATMENT &
DIAGNOSIS, 2015-2023 (USD MILLION)
TABLE 107 ASIA PACIFIC CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR TREATMENT BY TYPE 2015-2023 (USD MILLION)
TABLE 108 ASIA PACIFIC CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR DIAGNOSIS BY TYPE 2015-2023 (USD MILLION)
TABLE 109 ASIA PACIFIC CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR ELECTRODIAGNOSTIC
TESTING BY TYPE, 2015-2023 (USD MILLION)
TABLE 110 ASIA PACIFIC CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY ROUTE OF ADMINISTRATION 2015-2023 (USD MILLION)
TABLE 111 ASIA PACIFIC CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY END USERS 2015-2023 (USD MILLION)
TABLE 112 CHINA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY TREATMENT & DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 113 CHINA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR TREATMENT BY TYPE 2015-2023 (USD MILLION)
TABLE 114 CHINA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR DIAGNOSIS BY TYPE 2015-2023 (USD MILLION)
TABLE 115 CHINA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR ELECTRODIAGNOSTIC TESTING
BY TYPE, 2015-2023 (USD MILLION)
TABLE 116 CHINA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY ROUTE OF ADMINISTRATION 2015-2023 (USD MILLION)
TABLE 117 CHINA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY END USERS, 2015-2023 (USD MILLION)
TABLE 118 JAPAN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY TREATMENT & DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 119 JAPAN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR TREATMENT BY TYPE 2015-2023 (USD MILLION)
TABLE 120 JAPAN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR DIAGNOSIS BY TYPE 2015-2023 (USD MILLION)
TABLE 121 JAPAN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR ELECTRODIAGNOSTIC TESTING
BY TYPE, 2015-2023 (USD MILLION)
TABLE 122 JAPAN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY ROUTE OF ADMINISTRATION 2015-2023 (USD MILLION)
TABLE 123 JAPAN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY END USERS, 2015-2023 (USD MILLION)
TABLE 124 INDIA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY TREATMENT & DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 125 INDIA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR TREATMENT BY TYPE 2015-2023 (USD MILLION)
TABLE 126 INDIA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR DIAGNOSIS BY TYPE 2015-2023 (USD MILLION)
TABLE 127 INDIA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR ELECTRODIAGNOSTIC TESTING
BY TYPE, 2015-2023 (USD MILLION)
TABLE 128 INDIA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY ROUTE OF ADMINISTRATION 2015-2023 (USD MILLION)
TABLE 129 INDIA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY END USERS, 2015-2023 (USD MILLION)
TABLE 130 AUSTRALIA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY TREATMENT & DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 131 AUSTRALIA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR TREATMENT BY TYPE 2015-2023 (USD MILLION)
TABLE 132 AUSTRALIA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR DIAGNOSIS BY TYPE 2015-2023 (USD MILLION)
TABLE 133 AUSTRALIA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR ELECTRODIAGNOSTIC TESTING
BY TYPE, 2015-2023 (USD MILLION)
TABLE 134 AUSTRALIA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY ROUTE OF ADMINISTRATION 2015-2023 (USD MILLION)
TABLE 135 AUSTRALIA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY END USERS 2015-2023 (USD MILLION)
TABLE 136 REPUBLIC OF KOREA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY TREATMENT &
DIAGNOSIS, 2015-2023 (USD MILLION)
TABLE 137 REPUBLIC OF KOREA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR TREATMENT
BY TYPE, 2015-2023 (USD MILLION)
TABLE 138 REPUBLIC OF KOREA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR DIAGNOSIS BY TYPE 2015-2023 (USD MILLION)
TABLE 139 REPUBLIC OF KOREA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR
ELECTRODIAGNOSTIC TESTING BY TYPE, 2015-2023 (USD MILLION)
TABLE 140 REPUBLIC OF KOREA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY ROUTE OF
ADMINISTRATION, 2015-2023 (USD MILLION)
TABLE 141 REPUBLIC OF KOREA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY END USERS 2015-2023 (USD MILLION)
TABLE 142 REST OF ASIA PACIFIC CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY TREATMENT &
DIAGNOSIS, 2015-2023 (USD MILLION)
TABLE 143 REST OF ASIA PACIFIC CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR TREATMENT
BY TYPE, 2015-2023 (USD MILLION)
TABLE 144 REST OF ASIA PACIFIC CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR DIAGNOSIS
BY TYPE, 2015-2023 (USD MILLION)
TABLE 145 REST OF ASIA PACIFIC CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR
ELECTRODIAGNOSTIC TESTING BY TYPE, 2015-2023 (USD MILLION)
TABLE 146 REST OF ASIA PACIFIC CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY ROUTE OF
ADMINISTRATION, 2015-2023 (USD MILLION)
TABLE 147 REST OF ASIA PACIFIC CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY END USERS 2015-2023 (USD MILLION)
TABLE 148 MIDDLE EAST AND AFRICA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY REGION 2015-2023 (USD MILLION)
TABLE 149 MIDDLE EAST AND AFRICA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY TREATMENT &
DIAGNOSIS, 2015-2023 (USD MILLION)
TABLE 150 MIDDLE EAST AND AFRICA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR TREATMENT
BY TYPE, 2015-2023 (USD MILLION)
TABLE 151 MIDDLE EAST AND AFRICA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR DIAGNOSIS
BY TYPE, 2015-2023 (USD MILLION)
TABLE 152 MIDDLE EAST AND AFRICA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR
ELECTRODIAGNOSTIC TESTING BY TYPE, 2015-2023 (USD MILLION)
TABLE 153 MIDDLE EAST AND AFRICA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY ROUTE OF ADMINISTRATION, 2015-2023 (USD MILLION)
TABLE 154 MIDDLE EAST AND AFRICA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY END USERS 2015-2023 (USD MILLION)
TABLE 155 MIDDLE EAST CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY TREATMENT & DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 156 MIDDLE EAST CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR TREATMENT BY TYPE 2015-2023 (USD MILLION)
TABLE 157 MIDDLE EAST CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR DIAGNOSIS BY TYPE 2015-2023 (USD MILLION)
TABLE 158 MIDDLE EAST CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR ELECTRODIAGNOSTIC
TESTING BY TYPE, 2015-2023 (USD MILLION)
TABLE 159 MIDDLE EAST CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY ROUTE OF ADMINISTRATION 2015-2023 (USD MILLION)
TABLE 160 MIDDLE EAST CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY END USERS 2015-2023 (USD MILLION)
TABLE 161 AFRICA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY TREATMENT & DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 162 AFRICA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR TREATMENT BY TYPE 2015-2023 (USD MILLION)
TABLE 163 AFRICA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR DIAGNOSIS BY TYPE 2015-2023 (USD MILLION)
TABLE 164 AFRICA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET FOR ELECTRODIAGNOSTIC TESTING
BY TYPE, 2015-2023 (USD MILLION)
TABLE 165 AFRICA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY ROUTE OF ADMINISTRATION 2015-2023 (USD MILLION)
TABLE 166 AFRICA CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY MARKET, BY END USERS, 2015-2023 (USD MILLION)